Menu
Back to Journals » ClinicoEconomics and Outcomes Research » Volume 12
Original Research
Cost-Effectiveness of a JAK1/JAK2 Inhibitor vs a Biologic Disease-Modifying Antirheumatic Drug (bDMARD) in a Treat-to-Target Strategy for Rheumatoid Arthritis
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 8,219 | Dovepress* | 6,782+ | 1,287 | 8,069 | |
| PubMed Central* | 1,437 | 326 | 1,763 | ||
| Totals | 8,219 | 1,613 | 9,832 | ||
| *Since 15 April 2020 | |||||
View citations on PubMed Central and Google Scholar